Case Study: Global Top-10 Biopharmaceutical Company achieves 23% higher enrollment and 89% site adoption with OneStudyTeam

Top-10 Biopharma Improves Enrollment Efficiency Across Complex Oncology Trials

The Global Top-10 Biopharmaceutical Company, running complex oncology programs across ~30 countries and ~200 sites, was struggling with long protocols, extended medication washouts and rising competition for patients. These factors created blind spots in the pre‑randomization recruitment funnel and left the sponsor unsure which sites were actively recruiting. To address this, the company engaged OneStudyTeam and its StudyTeam platform.

OneStudyTeam deployed StudyTeam across the sponsor’s oncology trials, activated and trained site coordinators within weeks, and enabled near‑universal site uptake. StudyTeam’s Trial Board, Visit Window Calculator and multi‑trial pre‑screening tools delivered longitudinal patient visibility, reduced scheduling deviations, and made it easy to manage follow‑ups. As a result, sites using StudyTeam enrolled 23% more patients than non‑users, 89% of sites chose StudyTeam over their prior solution, and 100% of sites that adopted StudyTeam added another trial from the sponsor’s portfolio—giving the sponsor real‑time funnel visibility to target site support.